SLB
44
3
MSI
54
2
GOOGL
64
2
WBA
38
-3
HAL
30
-10
LLY
45
8
JCI
42
-2
NTRS
39
2
CCL
64
-6
TRV
37
3
RRC
58
6
CSCO
66
3
DHI
27
-9
STT
59
11
PEG
55
2
DVN
24
2
NWSA
71
2
AMAT
41
6
PYPL
47
-2
FDX
33
-11
SLB
44
3
MSI
54
2
GOOGL
64
2
WBA
38
-3
HAL
30
-10
LLY
45
8
JCI
42
-2
NTRS
39
2
CCL
64
-6
TRV
37
3
RRC
58
6
CSCO
66
3
DHI
27
-9
STT
59
11
PEG
55
2
DVN
24
2
NWSA
71
2
AMAT
41
6
PYPL
47
-2
FDX
33
-11
Financhill
Back

China Pharma Holding 10K Form

Sell
6

CPHI
China Pharma Holding

Last Price:
$0.19
Seasonality Move:
13.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPHI News And Ratings

See the #1 stock for the next 7 days that we like better than CPHI

CPHI Financial Statistics

Sales & Book Value

Annual Sales: $7M
Cash Flow: $-37.7K
Price / Cash Flow: 12.76
Annual Sales: $0.37
Price / Book: 0.53

Profitability

EPS (TTM): -0.33600
Net Income (TTM): $-4.7M
Gross Margin: $-281.1K
Return on Equity: -66.27%
Return on Assets: -31.32%

China Pharma Holding Earnings Forecast

Key China Pharma Holding Financial Ratios

  • The Gross Profit Margin over the past 20 years for CPHI is -4.01%.
  • The Selling, General & Administrative Expenses for CPHI have been equal to 32.04% of Gross Profit Margin.
  • The Research & Development expenses have been 3.42% of Revenue.
  • The Interest Expense is -10.84% of Operating Income.
  • The Net Earning history of CPHI is -43.91% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

China Pharma Holding Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CPHI
Website: chinapharmaholdings.com

Debt

Debt-to-Equity Ratio: 0.61
Current Ratio: 0.79
Quick Ratio: 0.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CPHI Technical Analysis vs Fundamental Analysis

Sell
6
China Pharma Holding (CPHI) is a Sell

Is China Pharma Holding a Buy or a Sell?